R&Dplatform

联系我们

国际针灸合作委员会关于变更办公地址的通知

中国民间中医医药研究开发协会国际针灸合作委员会

办公地点现在已经搬迁至西城区西直门南小街国英园一号楼824室,

同时为方便大家联系,固定电话已经变更

新号码010—58562339。特此通知。

地址:北京西城区西直门南小街国英园一号楼824室

邮编:100035

电话:010-58562339

传真:010-58562339

邮箱:cngjzj@163.com

网站(点击网址直接链接↓):http://www.cngjzj.com/

博客(点击网址直接链接↓):http://blog.sina.com.cn/cngjzj

交通路线图 (点击观看大图)

到西城区西直门南小街国英园一号楼行驶路线

机场线路1

从首都机场乘坐机场专线,在东直门站下车换乘地铁2号线开往西直门方向,在西直门站 C 口出站:

1、沿西直门内大街向东直行100米,右拐到西直门南小街,向南步行到丁字路口即到国英园1号楼楼下。

2、向南直行50米,绕过 国二招宾馆 沿着中大安胡同向东到西直门南小街,向南步行到丁字路口即到国英园1号楼楼下。

机场线路2

从首都机场内乘坐机场直达西单的大巴,在西单站下车,乘坐出租车到西直门南小街国英园1号楼。

附近公交地铁:

公交官园站:107路,运通106路

公交西直门南:387路,44路,800内环,816路,820内环,845路

地铁车公庄:地铁二号线

地铁西直门:地铁二号线

公交车公庄东:107路,118路,701路

公交车公庄北:209路,375路,392路

您现在的位置是: 首页 >> R&Dplatform >> R&Dplatform

Chengdu University of Traditional Chinese Medicine "Hand in Hand" Bixiopu Cancer

2018年12月31日

复制链接 打印 大 中 小

<



Chengdu University of Traditional Chinese Medicine "Hand in Hand" Bixiopu Cancer Research Institute: Joint Research and Development of New Cancer Drugs
Drama Squad 2018-10-20 01:10


This picture is taken from the People's Daily client. On the afternoon of October 9th, the signing ceremony of the strategic cooperation agreement between the Cancer Institute of Chengdu University of Chinese Medicine and the Bixiao Cancer Institute and the Logo of the Bixiopu Cancer Institute was held at the Wenjiang Campus of the school.
The event was attended by a large crowd, 1989 Nobel Prize winner in Physiology or Medicine, Academician of the American Academy of Sciences, Academician of the American Academy of Arts and Sciences, Professor Jiannuofu Bishop, Academician of the Royal Academy of Sciences, and Apple trademark designer. Mr. Rob Janoff, Professor Robert Lloyd, Academician of the Royal Academy of Sciences, and Professor Naishimisi, Academician of the Royal Academy of Sciences, Feiershe, director of Stanford University's Institute of Oncology, Weiermu, director of the University of Utah Cell Response and Regulation Program, and Steven, director of the Department of Developmental Genetics of Nanjing Medical University. , witnessed the strong association of Chinese and Western medicine and opened a new chapter in cancer prevention and treatment research.
President Yushuguang delivered a welcome speech. Cancer, he said, would be the leading cause of death in the twenty-first century, the most important obstacle to increasing life expectancy in countries around the world and one of the greatest health challenges facing humanity today. In the 100-year history of cancer research, surgical therapy, chemotherapy, radiation therapy, targeted therapy, and immunotherapy have emerged. American and Japanese scientists who discovered negative immunomodulatory cancer therapy have also won the 2018 Nobel Prize in Physiology or Medicine. Chinese medicine treatment is also one of the special treatments for cancer, which has the effect of reducing poison and increasing sensitivity in combination with chemotherapy and chemotherapy. It can effectively improve the clinical symptoms of patients and improve the quality of life; It can effectively improve the tumor stability rate and prolong the survival time. It can effectively improve the immune status and other characteristics and advantages of patients. Yushuguang pointed out that the cooperation between the Cancer Research Institute of Chengdu University of Traditional Chinese Medicine and the Bixiao Cancer Research Institute is a major event and joy for the Chengdu University of Traditional Chinese Medicine to achieve scientific development and leapfrog the development process. It is an important measure to speed up the "double first-class" construction and achieve academic revitalization of Chinese medicine. It will promote the accelerated progress of school connotation construction.
At the meeting, Professor Tianli, vice president of the Clinical Medical School / Affiliated Hospital, and Dr. Bixiao, director of the Yangdun Cancer Research Institute, signed a cooperation agreement on behalf of the two sides of the school and enterprises. The principal, Yushuguang, awarded the joint laboratory to the two sides. The cooperation between the Oncology Research Institute of Chengdu University of Traditional Chinese Medicine and the Bixiao Cancer Research Institute will be based on the western region of China and integrate the drug plant resources, traditional Chinese medicine, and the cancer foundation and transformation research in the Southwest region organically, through complementary advantages, cooperation and innovation. Design, discover, and develop breakthrough and innovative drugs and therapies that are more effective and have fewer side effects than traditional cancer therapies, benefiting more patients. According to feng Ming, director of the oncology research institute of Chengdu University of traditional Chinese medicine, the macro-guidance of Chinese medicine in the prevention and treatment of diseases has its own theoretical advantages, and Western medicine has modern scientific and technological advantages in drug extraction and drug analysis, and the two advantages complement each other. Like Tuyouyouqinghaosu's discovery and extraction, when Chinese medicine takes the fast train of modern scientific development, it will surely bring more "gifts" to the world.
The conference also held the launch ceremony of the Logo of the Bixiao Cancer Research Institute. The designer Jiannuofu explained the design concept. Jiannuofu, Li Xiaobu, Lloyd, Smith and other attendees signed congratulations on the Logo panel.
Dr Bixiao, Director of the Cancer Research Institute of Yangdun, gave a presentation on the direction of research and development of anti-cancer drugs.
After the meeting, Jiannuofu and other guests walked around the campus, visited the school museum, had close contact with the Chinese medicine culture, and personally experienced the wonderful massage of Chinese medicine.
It is understood that the Bixiao Cancer Institute is the only basic research institution in the world named after Professor Bishop for cancer treatment. Professor Bishop and Wamusi in the 1980s(Harold E. Professor Varmus) collaborated to discover the first human prooncogene C-Src. Their findings explain how cancer is formed from changes in normal genes in cells, bringing cancer research to the genetic level, and their proposed "oncogene" has become a milestone in the process of cancer biology exploration. At present, the Bixiao Cancer Research Institute has in-depth research in the fields of cell biology, small molecule RNA biology, cancer gene biology, cancer stem cells, and precision anti-cancer medicine. (Originally entitled: "School enterprises jointly develop new anti-cancer new drugs and new therapies. Chinese medicine will bring more gifts to the world.")